AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2244639 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall relapse rate after 3 months
Number of subjects: 50
Study 2244639 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo response maintenance
Number of subjects: 50
Study 357455 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg sublingual pentrinitrol
Number of subjects: 20
Study 357455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 31800360 — intervention group
Group type: EXPERIMENTAL
Intervention: Knack‐tutorial group
Number of subjects: 108
Study 31800360 — intervention group
Group type: COMPARATOR
Intervention: Diet/exercise tutorial group
Number of subjects: 108
Study 31687897 — intervention group
Group type: EXPERIMENTAL
Intervention: Preanesthetic consultation (PAC) with an anesthesiologist
Number of subjects: 80
Study 31687897 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PAC)
Number of subjects: 80
Study 27838874 — intervention group
Group type: EXPERIMENTAL
Intervention: red yeast rice + L. casei
Number of subjects: 60
Study 27838874 — intervention group
Group type: COMPARATOR
Intervention: red yeast rice + placebo
Number of subjects: 60
Study 26426683 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated disinfection method (Trophon EPR®)
Number of subjects: 240
Study 26426683 — intervention group
Group type: COMPARATOR
Intervention: Manual disinfection method (Mikrozid Sensitive® wipes)
Number of subjects: 240
Study 26426683 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 240
Study 23953975 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based early education and development program
Number of subjects: 738000
Study 23953975 — intervention group
Group type: COMPARATOR
Intervention: Matched control group (no intervention)
Number of subjects: 738000
Study 21247433 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation program
Number of subjects: 74
Study 19457007 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized performance feedback
Number of subjects: 95
Study 19457007 — intervention group
Group type: COMPARATOR
Intervention: No additional feedback (Control)
Number of subjects: 95
Study 17280744 — intervention group
Group type: EXPERIMENTAL
Intervention: MSP3-LSP (30 microg)
Number of subjects: 30
Study 17280744 — intervention group
Group type: COMPARATOR
Intervention: Tetanus toxoid vaccine (0.5 ml)
Number of subjects: 30
Study 14706056 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with newly diagnosed Type 1 diabetes
Number of subjects: 49
Study 14706056 — intervention group
Group type: EXPERIMENTAL
Intervention: Family members of children with Type 1 diabetes
Number of subjects: 49
Study 14706056 — intervention group
Group type: COMPARATOR
Intervention: Family members of control children
Number of subjects: 49
Study 11467632 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole, 30 mg administered nasogastrically in apple juice
Number of subjects: 33
Study 11467632 — intervention group
Group type: COMPARATOR
Intervention: Pantoprazole, 40 mg administered intravenously
Number of subjects: 33
Study 9830180 — intervention group
Group type: EXPERIMENTAL
Intervention: Screened group (patients presented the GHQ questionnaire to the doctor)
Number of subjects: 1589
Study 9830180 — intervention group
Group type: COMPARATOR
Intervention: Clinical judgement group (patients posted the GHQ questionnaire into a box)
Number of subjects: 1589
Study 9830180 — intervention group
Group type: EXPERIMENTAL
Intervention: Screened group
Number of subjects: 1589
Study 9830180 — intervention group
Group type: COMPARATOR
Intervention: Clinical judgement group
Number of subjects: 1589
Study 7912877 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 2.5 micrograms kg‐1 i.m. 60 min before induction and saline placebo i.v. 2 min prior to induction (DP group)
Number of subjects: 20
Study 7912877 — intervention group
Group type: COMPARATOR
Intervention: Midazolam 0.08 mg kg‐1 i.m. 60 min and fentanyl 1.5 micrograms kg‐1 i.v. 2 min before induction (MF group)
Number of subjects: 20
Study 7912877 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DP group)
Number of subjects: 20
Study 7912877 — intervention group
Group type: COMPARATOR
Intervention: Midazolam-fentanyl (MF group)
Number of subjects: 20
Study 7912877 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 2681556 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose metoclopramide (1 mg/kg x 4) and methylprednisolone (treatment A)
Number of subjects: 367
Study 2681556 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide (3 mg/kg x 2) combined with dexamethasone and diphenhydramine (treatment B)
Number of subjects: 367
Study 4594585 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-aided diagnosis
Number of subjects: 552
Study 4594585 — intervention group
Group type: COMPARATOR
Intervention: Senior clinician diagnosis
Number of subjects: 552
Study 30409925 — intervention group
Group type: EXPERIMENTAL
Intervention: High SPF sunscreen (SPF 50+, PA++++) applied once daily after bath or every 4 hours for outdoor exposure >4 hours for 3 months.
Number of subjects: 45
Study 30409925 — intervention group
Group type: EXPERIMENTAL
Intervention: High SPF sunscreen (SPF 50+, PA++++)
Number of subjects: 45
Study 28270498 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus with cisplatin and paclitaxel
Number of subjects: 145
Study 28270498 — intervention group
Group type: COMPARATOR
Intervention: Placebo with cisplatin and paclitaxel
Number of subjects: 145
Study 25434572 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) of the median nerve (25 Hz, 800 ms on/800 ms off) for 30 minutes
Number of subjects: 9
Study 25434572 — intervention group
Group type: COMPARATOR
Intervention: Control groups (young control and age-matched control)
Number of subjects: 9
Study 25434572 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) of the median nerve
Number of subjects: 9
Study 23558666 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium (18 μg)
Number of subjects: 30
Study 23558666 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 22015190 — intervention group
Group type: EXPERIMENTAL
Intervention: Shuxuetong injection and Tuina
Number of subjects: 120
Study 22015190 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation training
Number of subjects: 120
Study 19538913 — intervention group
Group type: EXPERIMENTAL
Intervention: Small group motivational interviewing
Number of subjects: 695
Study 19538913 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivationally enhanced peer theater
Number of subjects: 695
Study 19538913 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive alcohol‐education program
Number of subjects: 695
Study 19538913 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory analyses
Number of subjects: 695
Study 16770449 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field (PEMF) exposure (30 min, ≤400 microTpk, <3 kHz)
Number of subjects: 31
Study 16770449 — intervention group
Group type: COMPARATOR
Intervention: Sham exposure (placebo)
Number of subjects: 31
Study 15316798 — intervention group
Group type: EXPERIMENTAL
Intervention: TPM 100 mg/d
Number of subjects: 575
Study 15316798 — intervention group
Group type: COMPARATOR
Intervention: PROP 160 mg/d (active control)
Number of subjects: 575
Study 15316798 — intervention group
Group type: EXPERIMENTAL
Intervention: TPM 200 mg/d
Number of subjects: 575
Study 15316798 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 575
Study 11558484 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil
Number of subjects: 28
Study 11558484 — intervention group
Group type: COMPARATOR
Intervention: CNI
Number of subjects: 28
Study 9431627 — intervention group
Group type: EXPERIMENTAL
Intervention: Full intervention (combination of clinical and occupational intervention)
Number of subjects: 130
Study 9431627 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational intervention
Number of subjects: 130
Study 9431627 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 130
Study 7993832 — intervention group
Group type: EXPERIMENTAL
Intervention: i.m. dexamethasone and oral metoclopramide for delayed emesis
Number of subjects: 249
Study 7993832 — intervention group
Group type: COMPARATOR
Intervention: i.v. ondansetron plus dexamethasone or metoclopramide plus dexamethasone plus diphenhydramine for acute emesis
Number of subjects: 249
Study 3046657 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin 100 micrograms/kg
Number of subjects: 200
Study 3046657 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin 150 micrograms/kg
Number of subjects: 200
Study 3046657 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin 200 micrograms/kg
Number of subjects: 200
Study 3046657 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 micrograms/kg)
Number of subjects: 200
Study 31784906 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical muscle stimulation in combination with heat (EMS/H)
Number of subjects: 100
Study 31784906 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 100
Study 31347643 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh turmeric meal (400 mg curcumin)
Number of subjects: 0
Study 31347643 — intervention group
Group type: EXPERIMENTAL
Intervention: Turmeric powder meal (400 mg curcumin)
Number of subjects: 0
Study 31347643 — intervention group
Group type: COMPARATOR
Intervention: Curcumin powder meal (400 mg curcumin)
Number of subjects: 0
Study 27428476 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Θ burst rTMS to right inferior parietal lobule
Number of subjects: 0
Study 27428476 — intervention group
Group type: COMPARATOR
Intervention: Sham Θ burst rTMS to right inferior parietal lobule
Number of subjects: 0
Study 26304970 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer health coaching training
Number of subjects: 32
Study 23403817 — intervention group
Group type: EXPERIMENTAL
Intervention: Ridaforolimus 12.5mg intravenously once daily for 5 consecutive days every 2 weeks in a 4-week cycle
Number of subjects: 45
Study 23403817 — intervention group
Group type: EXPERIMENTAL
Intervention: Ridaforolimus
Number of subjects: 45
Study 21138476 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (5 mg/day, 2 hr before bedtime) for 2 months
Number of subjects: 30
Study 18303379 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable cornea compensation (VCC) of the GDxVCC
Number of subjects: 15
Study 17313006 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive electrode pulse electric stimulation at Taiyang (EX-HN 5), Sibai (ST 2), Qianzheng (Extra), Dicang (ST 4), once each day for 10 days (2 courses total).
Number of subjects: 276
Study 17313006 — intervention group
Group type: COMPARATOR
Intervention: Routine medicine (prednisone, dibazol, vitamin B complex, and Qianzheng Powder), once each day for 10 days (2 courses total).
Number of subjects: 276
Study 12913035 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term quitters
Number of subjects: 6613
Study 12913035 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent quitters
Number of subjects: 6613
Study 12913035 — intervention group
Group type: EXPERIMENTAL
Intervention: Never quitters
Number of subjects: 6613
Study 11471645 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% alkaline EDTA solution
Number of subjects: 0
Study 11471645 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% acid EDTA solution
Number of subjects: 0
Study 11471645 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% alkaline EDTA solution
Number of subjects: 0
Study 11471645 — intervention group
Group type: COMPARATOR
Intervention: 5.25% NaOCl
Number of subjects: 0
Study 11471645 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkaline tetrasodium salt (pH adjusted with HCl)
Number of subjects: 0
Study 11471645 — intervention group
Group type: COMPARATOR
Intervention: Disodium salt of EDTA
Number of subjects: 0
Study 9352141 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy non-smokers
Number of subjects: 104
Study 9352141 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 104
Study 8095779 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg guanabenz
Number of subjects: 30
Study 8095779 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg guanabenz
Number of subjects: 30
Study 8095779 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 3521373 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranial electrotherapy stimulation (CES)
Number of subjects: 40
Study 3521373 — intervention group
Group type: COMPARATOR
Intervention: Sham CES
Number of subjects: 40
Study 3521373 — intervention group
Group type: COMPARATOR
Intervention: Normal hospital routine controls
Number of subjects: 40
Study 31996209 — intervention group
Group type: EXPERIMENTAL
Intervention: Group antenatal care (G-ANC) in Nigeria
Number of subjects: 1075
Study 31996209 — intervention group
Group type: COMPARATOR
Intervention: Individual antenatal care (ANC) in Nigeria
Number of subjects: 1075
Study 31996209 — intervention group
Group type: EXPERIMENTAL
Intervention: Group antenatal care (G-ANC) in Kenya
Number of subjects: 1075
Study 31996209 — intervention group
Group type: COMPARATOR
Intervention: Individual antenatal care (ANC) in Kenya
Number of subjects: 1075
Study 29538635 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (1 g 6-hourly for 72 hours)
Number of subjects: 62
Study 29538635 — intervention group
Group type: COMPARATOR
Intervention: No acetaminophen (control group)
Number of subjects: 62
Study 26977740 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Level Laser Therapy (LLLT) applied intraorally with GaAlAs diode laser (wavelength, 810 nm; continuous mode, output power 0.3 W; 180 sec, 4 J/cm(2))
Number of subjects: 37
Study 26977740 — intervention group
Group type: COMPARATOR
Intervention: Control group (hand piece applied without laser activation)
Number of subjects: 37
Study 23872238 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnifying chromoendoscopy (MC)
Number of subjects: 70
Study 23872238 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasonography (EUS)
Number of subjects: 70
Study 23872238 — intervention group
Group type: COMPARATOR
Intervention: Observation time for MC
Number of subjects: 70
Study 22002571 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtransverse process wiring (group A)
Number of subjects: 64
Study 22002571 — intervention group
Group type: COMPARATOR
Intervention: Sublaminar wiring (group B)
Number of subjects: 64
Study 20482462 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants (n=107)
Number of subjects: 302
Study 20482462 — intervention group
Group type: COMPARATOR
Intervention: Non-participants (n=125)
Number of subjects: 302
Study 18326608 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol 100,000 IU
Number of subjects: 30
Study 18326608 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 16612753 — intervention group
Group type: EXPERIMENTAL
Intervention: Gold-plated silver tubes (GPR)
Number of subjects: 116
Study 16612753 — intervention group
Group type: COMPARATOR
Intervention: Silver Oxide-Impregnated Silastic Tubes (SPR)
Number of subjects: 116
Study 12580895 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen A (tropicamide 1.0% with phenylephrine 2.5%)
Number of subjects: 217
Study 12580895 — intervention group
Group type: COMPARATOR
Intervention: Regimen B (tropicamide 0.5% with phenylephrine 0.5%)
Number of subjects: 217
Study 12580895 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Regimen A and Regimen B
Number of subjects: 217
Study 11014720 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (400 mg intravenously once daily)
Number of subjects: 317
Study 8830357 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine Echocardiography (DE)
Number of subjects: 24
Study 8830357 — intervention group
Group type: EXPERIMENTAL
Intervention: Thallium Scintigraphy after i.v. nitrate bolus (SPET)
Number of subjects: 24
Study 8830357 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI) at rest
Number of subjects: 24
Study 8830357 — intervention group
Group type: COMPARATOR
Intervention: Functional recovery assessment with echocardiography at rest
Number of subjects: 24
Study 1595913 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% lidocaine and bretylium 1.5 mg/kg
Number of subjects: 0
Study 1595913 — intervention group
Group type: COMPARATOR
Intervention: 0.5% lidocaine
Number of subjects: 0
Study 1595913 — intervention group
Group type: EXPERIMENTAL
Intervention: bretylium administration
Number of subjects: 0
Study 1595913 — intervention group
Group type: COMPARATOR
Intervention: control treatments
Number of subjects: 0
Study 6151958 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam (2.7 mg mean final dose)
Number of subjects: 126
Study 6151958 — intervention group
Group type: COMPARATOR
Intervention: Doxepin (137.5 mg mean final dose)
Number of subjects: 126
Study 30825525 — intervention group
Group type: EXPERIMENTAL
Intervention: 9‐week Internet‐based CBT‐I program (Sleep Healthy Using the Internet (SHUTi))
Number of subjects: 210
Study 30825525 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care condition (online educational video about insomnia)
Number of subjects: 210
Study 30180081 — intervention group
Group type: EXPERIMENTAL
Intervention: Interprofessional team‐based program (SAFE Care)
Number of subjects: 0
Study 27001189 — intervention group
Group type: EXPERIMENTAL
Intervention: Waon therapy (once daily for 10 days, far infrared-ray dry sauna at 60℃ for 15 min, followed by 30 min bed rest covered with a blanket)
Number of subjects: 149
Study 27001189 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard medical therapy)
Number of subjects: 149
Study 25064777 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror therapy (MT) combined with conventional occupational therapy, physical therapy, and speech therapy for 5 d/wk, 6 h/d, over 3 weeks
Number of subjects: 20
Study 25064777 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy without MT
Number of subjects: 20
Study 22194183 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg daily (SSRI)
Number of subjects: 601
Study 22194183 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine 4 mg twice daily (NARI)
Number of subjects: 601
Study 20810159 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 25
Study 20810159 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 25
Study 20810159 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant apoA-IV
Number of subjects: 25
Study 17684985 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined spinal epidural anesthesia (CSEA)
Number of subjects: 37
Study 17684985 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal anesthesia
Number of subjects: 37
Study 15690223 — intervention group
Group type: EXPERIMENTAL
Intervention: PET/CT imaging
Number of subjects: 34
Study 15690223 — intervention group
Group type: COMPARATOR
Intervention: ceCT imaging
Number of subjects: 34
Study 15690223 — intervention group
Group type: COMPARATOR
Intervention: PET imaging
Number of subjects: 34
Study 14613380 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg daily
Number of subjects: 32
Study 14613380 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 150 mg twice daily
Number of subjects: 32
Study 14613380 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Omeprazole and Ranitidine
Number of subjects: 32
Study 14613380 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole to Ranitidine substitution
Number of subjects: 32
Study 14613380 — intervention group
Group type: EXPERIMENTAL
Intervention: Test kits
Number of subjects: 32
Study 10197825 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS (slow repetitive transcranial magnetic stimulation)
Number of subjects: 70
Study 10197825 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS (placebo control)
Number of subjects: 70
Study 7780057 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 micrograms of misoprostol
Number of subjects: 25
Study 7780057 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 25
Study 7780057 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (misoprostol and placebo)
Number of subjects: 25
Study 2107288 — intervention group
Group type: EXPERIMENTAL
Intervention: RATG
Number of subjects: 88
Study 2107288 — intervention group
Group type: COMPARATOR
Intervention: OKT3
Number of subjects: 88
Study 6244198 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g of 0.1% hydrocortisone 17‐butyrate ointment weekly for 4 weeks
Number of subjects: 20
Study 6244198 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g of 1% hydrocortisone ointment weekly for 4 weeks
Number of subjects: 20
Study 6244198 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 g of hydrocortisone 17‐butyrate weekly for 4 weeks
Number of subjects: 20
Study 6244198 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 g of hydrocortisone weekly for 4 weeks
Number of subjects: 20
Study 31121035 — intervention group
Group type: EXPERIMENTAL
Intervention: RT‐GS (radiotherapy gene signature)
Number of subjects: 502
Study 31121035 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemo‐GS (temozolomide gene signature)
Number of subjects: 502
Study 31121035 — intervention group
Group type: EXPERIMENTAL
Intervention: ChemoRT‐GS (combination therapy gene signature)
Number of subjects: 502
Study 28335622 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 122
Study 28335622 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant Medication
Number of subjects: 122
Study 25500320 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Rational Emotive Behavior Therapy (REBT)/CBT
Number of subjects: 88
Study 25500320 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy (sertraline)
Number of subjects: 88
Study 25500320 — intervention group
Group type: EXPERIMENTAL
Intervention: Group REBT/CBT plus pharmacotherapy
Number of subjects: 88
Study 25500320 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 88
Study 25500320 — intervention group
Group type: EXPERIMENTAL
Intervention: Group REBT/CBT
Number of subjects: 88
Study 23333819 — intervention group
Group type: EXPERIMENTAL
Intervention: 5s breath-hold maneuvers (0.28% CO, 55ppm NO)
Number of subjects: 9